Fundraising Fox

AnaCardio

Stockholm, SE · 5 known investors

AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development. The company was founded on breakthrough research from Karolinska Institutet targeting improved heart muscle contractility through a differentiated mechanism.

BiotechHealthtechMedical Devices

Founders & leadership

LH
Lars H. LundFounder

Investors · 5

3B Future Health Fund✓ verifiedMonaco · $12M
Industrifonden✓ verifiedStockholm · $1.1M – $4.3M
Novo Holdings✓ verifiedCopenhagen · $1.1M – $54M
Pureos Bioventures✓ verifiedPfäffikon
Sound Bioventures✓ verifiedMalmö

Funding

SEC filings, press & company announcements

$19M disclosed across 1 of 2 rounds · 2022–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Swedish company secures $19M to advance heart failure drug candidate AC01 - ArcticStartuparcticstartup.com · Jan 2025AnaCardio pumps €19 million into heart failure treatment innovation | EU-Startupseu-startups.com · Jan 2025AnaCardio raises $19m in funding round for heart failure candidate - Pharmafilepharmafile.com · Jan 2025Karolinska Development’s portfolio company AnaCardio raises SEK 205 million and reports positive Phase 1b data of AC01globenewswire.com · Jan 2025AnaCardio raises USD 19 million - NLSnordiclifescience.org · Jan 2025AnaCardio raises 150 million SEK in series A round co-led by Industrifonden – Industrifondenindustrifonden.com · Sep 2022

Frequently asked questions

What does AnaCardio do?
AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development. The company was founded on breakthrough research from Karolinska Institutet targeting improved heart muscle contractility through a differentiated mechanism.
Who founded AnaCardio?
AnaCardio was founded by Lars H. Lund.
Who are AnaCardio's investors?
AnaCardio's investors include 3B Future Health Fund, Industrifonden, Novo Holdings, Pureos Bioventures, Sound Bioventures.
How much funding has AnaCardio raised?
AnaCardio has disclosed $19M raised across 1 of its 2 known rounds.
Where is AnaCardio headquartered?
AnaCardio is headquartered in Stockholm, SE.